Valvular heart diseases represent one of the leading causes of cardiovascular morbidity and mortality, especially in developed countries, where the condition is associated with increased life expectancy and access to healthcare. Among the most common valvular diseases are aortic stenosis and mitral regurgitation, while the prevalence of aortic and tricuspid regurgitation has been rising, reaching epidemic proportions. Although surgical intervention has been the gold standard for treating these conditions for many years, a large proportion of elderly patients are not suitable candidates for invasive surgery. In the past two decades, new transcatheter treatment methods have been developed as a less invasive and effective alternative. (1, 2) The aim of this presentation is to showcase the new transcatheter methods for treating valvular heart diseases used at the Interventional Cardiology Department of the University Hospital Center Rijeka, with a focus on their application and benefits for high-risk patients.